- Home
- HALO vs HLNE Comparison
HALO vs HLNE Comparison
Compare HALO & HLNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HALO
- HLNE
- Stock Information
- Founded
- HALO 1998
- HLNE 1991
- Country
- HALO United States
- HLNE United States
- Employees
- HALO N/A
- HLNE N/A
- Industry
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- HLNE Investment Managers
- Sector
- HALO Health Care
- HLNE Finance
- Exchange
- HALO Nasdaq
- HLNE Nasdaq
- Market Cap
- HALO 7.4B
- HLNE 6.2B
- IPO Year
- HALO N/A
- HLNE 2017
- Fundamental
- Price
- HALO $52.81
- HLNE $136.69
- Analyst Decision
- HALO Buy
- HLNE Hold
- Analyst Count
- HALO 9
- HLNE 6
- Target Price
- HALO $63.56
- HLNE $160.67
- AVG Volume (30 Days)
- HALO 1.7M
- HLNE 792.2K
- Earning Date
- HALO 08-05-2025
- HLNE 08-05-2025
- Dividend Yield
- HALO N/A
- HLNE 1.59%
- EPS Growth
- HALO 55.40
- HLNE 46.35
- EPS
- HALO 3.76
- HLNE 5.41
- Revenue
- HALO $1,084,306,000.00
- HLNE $712,963,000.00
- Revenue This Year
- HALO $25.77
- HLNE $0.05
- Revenue Next Year
- HALO $18.01
- HLNE $17.78
- P/E Ratio
- HALO $14.04
- HLNE $25.10
- Revenue Growth
- HALO 25.64
- HLNE 28.73
- 52 Week Low
- HALO $42.01
- HLNE $115.52
- 52 Week High
- HALO $70.51
- HLNE $203.72
- Technical
- Relative Strength Index (RSI)
- HALO 41.21
- HLNE 31.70
- Support Level
- HALO $53.54
- HLNE $132.94
- Resistance Level
- HALO $55.60
- HLNE $139.20
- Average True Range (ATR)
- HALO 1.24
- HLNE 4.23
- MACD
- HALO 0.09
- HLNE -1.98
- Stochastic Oscillator
- HALO 4.62
- HLNE 17.53
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About HLNE Hamilton Lane Incorporated
Hamilton Lane Inc is a private market investment solutions provider in the United States. It works with its clients to conceive, structure, build out, manage and monitor portfolios of private markets funds and direct investments, and it helps them access a set of such investment opportunities around the world. The company offers a range of investment solutions across a range of private markets, including private equity, private credit, real estate, infrastructure, natural resources, growth equity, venture capital and impact. The company generate revenues mainly from management and advisory fees.